Publication Name	World Journal of Clinical Oncology
Manuscript ID	17551
Country	United States

Received	2015-03-12 08:34
Peer-Review Started	2015-03-12 18:50
To Make the First Decision	2015-05-13 19:51
Return for Revision	2015-05-18 19:36
Revised	2015-06-06 00:00
Second Decision	2015-06-12 16:33
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2015-06-19 17:56
Articles in Press
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2015-09-25 10:22
Publish the Manuscript Online	2015-10-13 10:26

ISSN	2218-4333 (online)
Open Access	This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	© The Author(s) 2015. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Oncology
Manuscript Type	Prospective Study
Article Title	Effects of selenomethionine on acute toxicities from concurrent chemoradiation for inoperable stage Ⅲ non-small cell lung cancer
Manuscript Source	Unsolicited Manuscript
All Author List	Michael Mix, Nithya Ramnath, Jorge Gomez, Charles de Groot, Saju Rajan, Shiva Dibaj, Wei Tan, Youcef Rustum, Michael B Jameson and Anurag K Singh
Funding Agency and Grant Number	Funding Agency Grant Number Health Research Council of New Zealand
Corresponding Author	Anurag K Singh, MD, Professor, Director, Department of Radiation Medicine, Roswell Park Cancer Institute, Elm and Carlton Streets, Buffalo, NY 14263, United States. anurag.singh@roswellpark.org
Key Words	Selenium; Chemoprotective; Radioprotector; Toxicity; Radiotherapy
Core Tip	This was a prospective international phase Ⅱ trial with 16 patients seeking to evaluate the effect of selenomethionine on acute toxicity in the setting of concurrent chemoradiaiton for locally advanced, inoperable non-small cell lung cancer. Selenium proved to be well tolerated and led to significantly reduced rates of myelosuppression.
Publish Date	2015-10-13 10:26
Citation	Mix M, Ramnath N, Gomez J, de Groot C, Rajan S, Dibaj S, Tan W, Rustum Y, Jameson MB, Singh AK. Effects of selenomethionine on acute toxicities from concurrent chemoradiation for inoperable stage Ⅲ non-small cell lung cancer. World J Clin Oncol 2015; 6(5): 156-165
URL	http://www.wjgnet.com/2218-4333/full/v6/i5/156.htm
DOI	http://dx.doi.org/10.5306/wjco.v6.i5.156

Full Article (PDF)	WJCO-6-156.pdf
Full Article (Word)	WJCO-6-156.doc
Manuscript File	17551-Review.docx
Answering Reviewers	17551-Answering reviewers.pdf
Audio Core Tip	17551-Audio core tip.wav
Biostatistics Review Certificate	17551-Biostatistics statement.pdf
Clinical Trial Registration Statement	17551-Clinical trial registration statement.pdf
Conflict-of-Interest Disclosure Form	17551-Conflict-of-interest statement.pdf
Copyright License Agreement	17551-Copyright assignment.pdf
Signed Informed Consent Form(s) or Document(s)	17551-Clinical trial registration statement.pdf
Institutional Review Board Approval Form or Document	17551-Institutional review board statement.pdf
Peer-review Report	17551-Peer-review(s).pdf
Scientific Misconduct Check	17551-Scientific misconduct check.pdf
Scientific Editor Work List	17551-Scientific editor work list.pdf